Latest papers

Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.

[Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].

Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008.

The safety of rubella vaccine in pregnancy.

Still fighting rubella.

Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine.

Environmental risk factors for the development of psoriatic arthritis: results from a case-control study.

A cluster of rubella in Malta, December 2007--January 2008.

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.

Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.

Rubella in pregnancy.

Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.

Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences.

Factsheet. Rubella.

Medical practices for prevention of perinatal infections in Puerto Rico.

Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.

[Rubella in Russia: variability of the infectious agent during the period of vaccine prophylaxis].

Progress in measles and rubella elimination in Iran.

Rubella immunity and vaccination coverage of the population of northern Greece in 2006.

Congenital rubella syndrome: the end is in sight.